Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shenmishu
- Development stage
- Unknown
- Lead developer
- Zhang Qi
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Shenmishu is a Traditional Chinese Medicine (TCM) formulation developed by National TCM Master Zhang Qi, primarily used for the treatment of chronic cystitis and 'Laolin syndrome' (recurrent urinary tract infections associated with physical exhaustion). The formula is designed to address the TCM patterns of kidney deficiency and damp-heat in the bladder. It typically functions by clearing heat, resolving dampness, and tonifying the kidneys to improve urinary function and reduce recurrence of infections. It is widely utilized as a hospital preparation within the Heilongjiang University of Chinese Medicine hospital system.
- Brand names
- Shenmishu
- Other names
- Shenmishu GranulesShenmishu Capsule
Beyond the preview
Go deeper on Shenmishu.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shenmishu.